REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

08/06/2018 11:55

RNS Number : 7997Q
Hikma Pharmaceuticals Plc
08 June 2018
 


 
Hikma Pharmaceuticals PLC - EIP Awards
 
LONDON, 8 June 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)

(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee has made the following nil cost option under the Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan (the "EIP") to a Person Discharging Managerial Responsibility ("PDMR") of the Company.
The Award under the EIP was made on 7 June 2018 at a price of 1,035 pence per Ordinary Share (being the average price for the 30-day period prior to 31 December 2017, in accordance with the EIP rules) as follows:
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Surendera Tyagi



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Surendera Tyagi




2


Reason for the notification




a)


Position/status


Chief Scientific Officer and Global Head of R&D




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


The Company granted the named individual above a nil-cost option award to acquire Shares under Element C of the 2014 Executive Incentive Plan (EIP). Shares under Element C EIP award will vest after 3 years, subject to continued employment.




c)


Price(s) and volume(s)


Price(s): £10.35
Volume(s): 28,818




d)


Aggregated information


N/A




e)


Date of the transaction


7 June 2018




f)


Place of the transaction


London Stock Exchange (XLON)



 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBGGDLLSGBGII